Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ocular Hypertension
Related studies linked through entity extraction aliases.
An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
- Status
- COMPLETED
- Phase
- N/A
Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
- Status
- COMPLETED
- Phase
- PHASE2
Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH
- Status
- WITHDRAWN
- Phase
- PHASE3
An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation
- Status
- TERMINATED
- Phase
- N/A
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
- Status
- COMPLETED
- Phase
- PHASE2
Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia
- Status
- WITHDRAWN
- Phase
- PHASE4
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
- Status
- COMPLETED
- Phase
- PHASE2
ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
- Status
- COMPLETED
- Phase
- PHASE4
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
- Status
- COMPLETED
- Phase
- N/A
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
- Status
- COMPLETED
- Phase
- N/A
A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy
- Status
- COMPLETED
- Phase
- N/A
Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Status
- COMPLETED
- Phase
- N/A
A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)
- Status
- COMPLETED
- Phase
- PHASE4